Effect of EZH2 regulation of the JAK2/STAT3 signaling pathway on proliferation and apoptosis in non‑small cell lung cancer cells
Oncology Reports · 2026
DOI: 10.3892/or.2026.9190 ↗Kurz gefasst
Fachartikel in der Zeitschrift Oncology Reports, 2026. Verfasst von Shuang Wu und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiothoracic Surgery, Yantaishan Hospital, Yantai, Shandong 264100, P.R. China. Hauptthemen laut MEDLINE: Enhancer of Zeste Homolog 2 Protein, Carcinoma, Non-Small-Cell Lung, Janus Kinase 2, STAT3 Transcription Factor. Die Arbeit nennt 44 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiothoracic Surgery, Yantaishan Hospital, Yantai, Shandong 264100, P.R. China.
- Department of Thoracic Surgery, Yantai Yuhuangding Hospital, Yantai, Shandong 264000, P.R. China.
Zitieren
APA
Wu, S., & Zhang, W. (2026). Effect of EZH2 regulation of the JAK2/STAT3 signaling pathway on proliferation and apoptosis in non‑small cell lung cancer cells. Oncology Reports. https://doi.org/10.3892/or.2026.9190
Vancouver
Wu S, Zhang W. Effect of EZH2 regulation of the JAK2/STAT3 signaling pathway on proliferation and apoptosis in non‑small cell lung cancer cells. Oncology Reports. 2026. doi:10.3892/or.2026.9190
BibTeX
@article{Wu2026,
author = {Wu, Shuang and Zhang, Wei},
title = {Effect of EZH2 regulation of the JAK2/STAT3 signaling pathway on proliferation and apoptosis in non‑small cell lung cancer cells},
journal = {Oncology Reports},
year = {2026},
doi = {10.3892/or.2026.9190}
}
EUVIMED